跳至主要内容
临床试验/ISRCTN73916115
ISRCTN73916115已完成未知

An international randomised controlled trial to establish the effects of early intensive blood pressure lowering in patients with intracerebral haemorrhage

ational Health and Medical Research Council (NHMRC) (Australia)0 个研究点目标入组 2,839 人开始时间: 2008年7月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
2,839

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients with computed tomography (CT)-confirmed spontaneous intracerebral haemorrhage (ICH)
  • 2. Elevated systolic blood pressure (greater than 150 mmHg and less than 220 mmHg)
  • 3. Capacity to commence randomly assigned treatment within 6 hours of onset of ICH
  • 4. Able to be 'actively' treated and admitted to a monitored facility
  • 5. Male and female, aged older than 18 years old

排除标准

  • 1. Clear indication or contraindication to intensive BP lowering
  • 2. Evidence ICH secondary to a structural abnormality
  • 3. Use of thrombolytic agent
  • 4. Previous ischaemic stroke within 30 days
  • 5. A very high likelihood that the patient will die within the next 24 hours on the basis of clinical and/or radiological criteria
  • 6. Score of 3 - 5 on the Glasgow Coma Scale (indicating deep coma)
  • 7. Significant pre-stroke disability or advanced dementia
  • 8. Planned early neurological intervention
  • 9. Participation in another clinical trial
  • 10. A high likelihood that the patient will not adhere to the study treatment and follow-up regimen

研究者

发起方
ational Health and Medical Research Council (NHMRC) (Australia)

相似试验